BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9127492)

  • 1. Arabidopsis dihydropteroate synthase: general properties and inhibition by reaction product and sulfonamides.
    Prabhu V; Lui H; King J
    Phytochemistry; 1997 May; 45(1):23-7. PubMed ID: 9127492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydropteroate synthase from Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition.
    Vinnicombe HG; Derrick JP
    Biochem Biophys Res Commun; 1999 May; 258(3):752-7. PubMed ID: 10329458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoplasma gondii: characterization of a mutant resistant to sulfonamides.
    Pfefferkorn ER; Borotz SE; Nothnagel RF
    Exp Parasitol; 1992 May; 74(3):261-70. PubMed ID: 1582478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone).
    Voeller D; Kovacs J; Andrawis V; Chu E; Masur H; Allegra C
    J Infect Dis; 1994 Feb; 169(2):456-9. PubMed ID: 8106784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors.
    Fernley RT; Iliades P; Macreadie I
    Anal Biochem; 2007 Jan; 360(2):227-34. PubMed ID: 17134675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium.
    Chio LC; Bolyard LA; Nasr M; Queener SF
    Antimicrob Agents Chemother; 1996 Mar; 40(3):727-33. PubMed ID: 8851601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity of sulfones and sulfonamides on dihydropteroate synthetase from Neisseria meingitidis.
    Ho RI; Corman L; Mores SA; Schneider H
    Antimicrob Agents Chemother; 1975 Jun; 7(6):758-63. PubMed ID: 808157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum.
    Triglia T; Menting JG; Wilson C; Cowman AF
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13944-9. PubMed ID: 9391132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the catalytic mechanism of dihydropteroate synthase: elucidating the differences between the substrate and inhibitor.
    Chotpatiwetchkul W; Boonyarattanakalin K; Gleeson D; Gleeson MP
    Org Biomol Chem; 2017 Jul; 15(26):5593-5601. PubMed ID: 28639657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
    Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
    J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of dihydropteroate in Saccharomyces cerevisiae.
    Bayly AM; Macreadie IG
    FEMS Microbiol Lett; 2002 Aug; 213(2):189-92. PubMed ID: 12167536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthase.
    Valderas MW; Andi B; Barrow WW; Cook PF
    Biochim Biophys Acta; 2008 May; 1780(5):848-53. PubMed ID: 18342015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs.
    Zhang Y; Meshnick SR
    Antimicrob Agents Chemother; 1991 Feb; 35(2):267-71. PubMed ID: 2024960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.
    Allegra CJ; Boarman D; Kovacs JA; Morrison P; Beaver J; Chabner BA; Masur H
    J Clin Invest; 1990 Feb; 85(2):371-9. PubMed ID: 2298911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents.
    Zhao Y; Shadrick WR; Wallace MJ; Wu Y; Griffith EC; Qi J; Yun MK; White SW; Lee RE
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3950-4. PubMed ID: 27423480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
    Hong YL; Hossler PA; Calhoun DH; Meshnick SR
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1756-63. PubMed ID: 7486915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase.
    Achari A; Somers DO; Champness JN; Bryant PK; Rosemond J; Stammers DK
    Nat Struct Biol; 1997 Jun; 4(6):490-7. PubMed ID: 9187658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate synthesis in higher-plant mitochondria: coupling between the dihydropterin pyrophosphokinase and the dihydropteroate synthase activities.
    Mouillon JM; Ravanel S; Douce R; Rébeillé F
    Biochem J; 2002 Apr; 363(Pt 2):313-9. PubMed ID: 11931659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of Burkholderia cenocepacia dihydropteroate synthase in the apo-form and complexed with the product 7,8-dihydropteroate.
    Morgan RE; Batot GO; Dement JM; Rao VA; Eadsforth TC; Hunter WN
    BMC Struct Biol; 2011 May; 11():21. PubMed ID: 21554707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase.
    Dennis ML; Lee MD; Harjani JR; Ahmed M; DeBono AJ; Pitcher NP; Wang ZC; Chhabra S; Barlow N; Rahmani R; Cleary B; Dolezal O; Hattarki M; Aurelio L; Shonberg J; Graham B; Peat TS; Baell JB; Swarbrick JD
    Chemistry; 2018 Feb; 24(8):1922-1930. PubMed ID: 29171692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.